AEGEAN Surgical Outcomes
Phase III AEGEAN: Analysis of Surgery-Related Outcomes With Neoadjuvant Durvalumab + CT Followed by Adjuvant Durvalumab in Resectable NSCLC

Released: September 15, 2023

Activity

Progress
1
Course Completed